Picture of Genetic Analysis As logo

GEAN Genetic Analysis As Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Genetic Analysis As, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.

C2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-6.94-22.1-29-28.3-23.8
Depreciation
Non-Cash Items5.113.3-3.152.73-0.89
Other Non-Cash Items
Changes in Working Capital-7.026.08-0.0171.261.9
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Other Operating Cash Flow
Cash from Operating Activities-6.36-6.56-27.6-19.5-17.2
Capital Expenditures-8.23-5.18-1.95-0.227-0.643
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items0.018-0.5
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-8.23-5.18-1.94-0.227-1.14
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-1.6431.952.2-1.89.34
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-16.220.222.6-21.5-9.03